Ptsd - Articles - Page 2 | CARLAT PUBLISHING

Overdiagnosis in Psychiatry

September 10, 2021

Joel Paris, MD

Professor emeritus at McGill University, and senior psychiatrist and research associate at Sir Mortimer B. Davis-Jewish General Hospital. Dr. Paris is the former editor of the Canadian Journal of Psychiatry and the author of 25 books including Overdiagnosis in Psychiatry, 2nd ed. (Oxford University Press; 2020). Dr. Paris has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Joel Paris explains why adult ADHD, depression, bipolar II, PTSD, and borderline personality are overdiagnosed in psychiatry at the expense of schizophrenia.

Turning Nightmares Into Dreams

August 3, 2021

Barry Krakow, MD

Barry Krakow, MD

Dr. Krakow is a board-certified sleep medicine specialist practicing in Savannah, GA following a 30-year research career that helped spearhead the movement to address sleep disorders in psychiatric patients. Dr. Krakow has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

When patients have more than one nightmare a week, it’s probably affecting their mental health. Barry Krakow has developed a simple behavioral therapy that reduces nightmares, and in this interview he explains how to apply it during brief and long visits.

Two Negative Studies of Mirtazapine and Riluzole for PTSD in Veterans

June 29, 2021

Richard Moldawsky, MD.

Richard Moldawsky, MD. Dr. Moldawsky has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Medications don’t have a good track record in PTSD, particularly in combat related trauma. Here we review two controlled trials where an old standby (mirtazapine) and a hopeful contender (riluzole) come up short.

Shining a Light on PTSD

June 29, 2021

Edmund S. Higgins, MD.

Edmund Higgins, MD Dr. Higgins has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

This first-of-its-kind study looked at lightbox in PTSD with a randomized, placebo-controlled design.

A Review of Medications for PTSD, With a Focus on Topiramate

May 4, 2021

Paul Riordan, MD.

Paul Riordan, MD. Assistant Consulting Professor of Psychiatry, Duke University. Dr. Riordan has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Topiramate is not first-line in PTSD, but it does have a role, particularly when alcohol use is part of the picture.

Mood, Cognition, and Metabolic Health

March 26, 2021

Rodrigo Barbachan Mansur, MD

Rodrigo Barbachan Mansur, MD

Assistant Professor, Division of Brain and Therapeutics, University of Toronto. Dr. Mansur has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Does eszopiclone (Lunesta) have therapeutic effects beyond insomnia? Possibly in depression and anxiety, but the jury is still out in PTSD.

Uncertain Results for Eszopiclone in PTSD

March 26, 2021

Thomas Jordan, MD.

Thomas Jordan, MD. Dr. Jordan has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

The idea that good sleep promotes mental health has led researchers to test whether hypnotics have psychiatric benefits beyond their effects on sleep.

Treating Pandemic-Associated Trauma in Children and Adolescents

March 12, 2021

Alan Steinberg, PhD and Naser Ahmadi, MD, PhD

Alan Steinberg, PhD Associate Director of the National Center for Child Traumatic Stress at UCLA.

Naser Ahmadi, MD, PhD Assistant Professor of Psychiatry at UCLA. Dr. Steinberg and Dr. Ahmadi have disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity.

In the age of COVID-19, clinicians need to assess for specific pandemic-related impacts on children and adolescents. UCLA has a new COVID-19 PTSD screen and they have also developed an effective intervention that targets and manages trauma triggers to address suicidality in children and adolescents for use in urgent settings.

Exposure Therapy Efficacious for PTSD Co-Occurring With Alcohol Use Disorder

November 22, 2019

Brian Frankel, MD

Brian Frankel, MD Dr. Frankel has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Prolonged exposure is one of the best treatments available for patients with PTSD. This study examines the advantages of using prolonged exposure for patients who have PTSD with co-occurring alcohol use disorder.

Is Paxil the Best SSRI for Anxiety?

August 30, 2019

Chris Aiken, MD

Chris Aiken, MD Dr. Aiken has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Paxil built its reputation as the best SSRI for anxiety, but the data suggests the opposite.